A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1997
10/02/1997	DE19612529A1 New antimicrobial plant protectants
10/02/1997	DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997	DE19612291A1 Arzneimittelzubereitungen enthaltend tumorhemmend wirkende Ruthenium(III)-Komplexe Pharmaceutical preparations containing tumor-inhibiting action ruthenium (III) complexes
10/02/1997	DE19611953A1 Verwendung von ungesättigten Monocarbonsäuren gegen Superinfektionen Use of unsaturated monocarboxylic acids against superinfection
10/02/1997	CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997	CA2250570A1 Formulations of ob protein
10/02/1997	CA2250459A1 Methods of treating venomous bites and stings
10/02/1997	CA2250403A1 Treatment of cystic disease with tnf-a
10/02/1997	CA2250383A1 Acne treatment
10/02/1997	CA2250332A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997	CA2250241A1 Arylamino fused pyridines and pyrimidines
10/02/1997	CA2250187A1 Composition comprising olanzapine and a drug useful in the treatment of pain for use in the treatment of pain
10/02/1997	CA2250186A1 Method for treating migraine pain
10/02/1997	CA2250173A1 Cytochrome p450 transducing retroviral vectors
10/02/1997	CA2250155A1 Anesthetic method
10/02/1997	CA2250099A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
10/02/1997	CA2250058A1 Recombinant pox virus encoding myelin protein for therapy
10/02/1997	CA2250053A1 Polysaccharide microspheres for the pulmonary delivery of drugs
10/02/1997	CA2250042A1 Treating pain using a synergistic combination of an atypical antipsychotic and a drug used in treatment of pain
10/02/1997	CA2250034A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997	CA2250009A1 Diclofenac/gamma-cyclodextrin inclusion compounds
10/02/1997	CA2249999A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
10/02/1997	CA2249998A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997	CA2249985A1 Tumour necrosis factor alpha convertase
10/02/1997	CA2249652A1 Method of treating common cold or allergic rhinitis
10/02/1997	CA2249598A1 Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
10/02/1997	CA2249580A1 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof
10/02/1997	CA2249578A1 Polyethylene glycol esters of polyunsaturated fatty acids
10/02/1997	CA2249455A1 Precursors of catalytic antibodies
10/02/1997	CA2249454A1 Diabetes treatment
10/02/1997	CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997	CA2249212A1 Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide
10/02/1997	CA2249208A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
10/02/1997	CA2248874A1 Tetrahydro-beta-carboline compounds
10/02/1997	CA2248873A1 Method for treating pain
10/02/1997	CA2248675A1 Cyclic nucleotide phosphodiesterase
10/02/1997	CA2248318A1 Growth factor htter36
10/01/1997	EP0798298A1 Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as active ingredient
10/01/1997	EP0798295A1 Novel amidinonaphthyl derivative or salt thereof
10/01/1997	EP0798292A1 Aniline derivatives having nitrogen monoxide synthase inhibitory activity
10/01/1997	EP0798001A2 Collagen containing preparations for strengthening bone
10/01/1997	EP0797999A2 Formulations of obesity protein
10/01/1997	EP0797995A2 Use of a 5-HT2 receptor antagonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis
10/01/1997	EP0797994A2 Use of one or more 5-HT2 receptor antagonists in the manufacture of a medicament for treating the symptoms of venomous bites and stings
10/01/1997	EP0797993A1 Compostions comprising l-carnitine or derivatives thereof and antioxidants
10/01/1997	EP0797992A2 Use of taurine, homotaurine and/or methionine for inducing analgesia or anesthesia and treating or preventing ischaemic injury
10/01/1997	EP0797991A1 Extended release formulation containing venlafaxine
10/01/1997	EP0797990A2 Use of steroid antagonists for the treatment and prophylaxis of dementia-related disorders
10/01/1997	EP0797989A1 Solid pharmaceutical composition comprising leflunomid
10/01/1997	EP0797988A2 Anti-angiogenic compositions and methods of use
10/01/1997	EP0797986A1 Veterinary compositions containing antibacterials for intramammary use
10/01/1997	EP0797985A1 Use of an extract of iridaceas in the treatment of skin wrinkles
10/01/1997	EP0797983A2 Use of methyl ethers in cosmetic and/or pharmaceutical preparations
10/01/1997	EP0797981A1 Use of a simarouba extract for the preparation of a skin cell culture medium
10/01/1997	EP0797917A1 Iodine/resin disinfectant and a procedure for the preparation thereof
10/01/1997	EP0797676A2 Recombinant adenoviral vector and methods of use
10/01/1997	EP0797581A1 Novel protein tyrosine kinase, jak3
10/01/1997	EP0797579A1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
10/01/1997	EP0797576A1 Alkyl substituted piperadinyl and piperazinyl anti-aids compounds
10/01/1997	EP0797575A1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/01/1997	EP0797567A1 Novel amino acid derivatives with improved multi-drug resistance activity
10/01/1997	EP0797564A1 Lignans, a process for their production and pharmaceutical compositions and uses thereof
10/01/1997	EP0797456A1 Anticancer drug with a cytostatic and a contrasting agent
10/01/1997	EP0797455A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c
10/01/1997	EP0797454A1 Improved adenoviral vectors and producer cells
10/01/1997	EP0797453A1 Composition for treatment of malignant tumors and their metastases
10/01/1997	EP0797451A2 Compositions containing hemicelluloses and polyphenols for treating gastrointestinal disorders
10/01/1997	EP0797448A2 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative
10/01/1997	EP0797445A2 Use of bioassimilable boron compounds for the control of subviral pathogenic agents
10/01/1997	EP0797444A1 Kit for osteoporosis treatment cycle
10/01/1997	EP0797443A1 A pharmaceutical composition with improved bio-availability of inositol phosphate
10/01/1997	EP0797442A1 Treatment of optic neuritis
10/01/1997	EP0797441A1 Pharmaceutical composition comprising lamotrigine
10/01/1997	EP0797440A1 The treatment of autoimmune disease using 2-amino purine derivatives
10/01/1997	EP0797439A1 Use of pramipexole as a neuroprotective agent
10/01/1997	EP0797438A1 Inhibition of retroviral ltr promoters by calcium response modifiers
10/01/1997	EP0797437A1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNF$g(a)
10/01/1997	EP0797432A1 Oil-in-water emulsions
10/01/1997	EP0797427A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
10/01/1997	EP0707587B1 Pharmacologically active enantiomers
10/01/1997	EP0701553B1 Arylpyrazole fungicides
10/01/1997	EP0596015B1 Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
10/01/1997	EP0533790B1 New salt form of 5-difluoromethoxy-2- [3,4-dimethoxy-2-pyridyl)methylsulfinyl-1h-benzimidazole
10/01/1997	EP0303697B1 Derivatives of physiologically active substance k-252
10/01/1997	CN1161045A Method of producing starch decomposition products
10/01/1997	CN1161041A Heterocycle-condensed morphinoid derivatives
10/01/1997	CN1161040A Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
10/01/1997	CN1161039A Novel melatonin agonist 'beta'-carboline derivatives and analogs with a naphthalenic structure, method for their preparation and their use as drugs
10/01/1997	CN1161037A Substituted spiroalkylamino and spiroalkoxy-heterocycles, process for preparing the same and their use as pesticides and fungicides
10/01/1997	CN1161035A Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
10/01/1997	CN1161000A Topical ophthalmic formulations containing Doxepin derivatives for treating allergic eye diseases
10/01/1997	CN1160999A Non-irritation, non-sensitizing non-ototoxic otic antibacterial compositions
10/01/1997	CN1160998A Method of inhibiting conditions associated with neuropeptide Y
10/01/1997	CN1160716A New compounds derived from boronic acid, process for their preparation and pharmaceutical compositions containing them
10/01/1997	CN1160706A Extraction method of unsaturated fatty acid from fish oil
10/01/1997	CN1160548A Process for producing Qingkailing powder injection
10/01/1997	CN1160539A Scar inhibitor and its compounding process
10/01/1997	CN1160538A Lentinus edodes polysaccharide injecta and its preparation
10/01/1997	CN1036009C Derivative of 2-(thien-2-yl) imidazo(2,1-b)-benzothiazole-3-acetic acid, preparation and pharmaceutical application of same
10/01/1997	CN1036008C 2-substituted methyl-2,3-dihydroimidazole£1,2-C\| quinazoline-5-one) thione and its preparation and usage

1 ... 6743 6744 6745 6746 6747 6748 6749 6750 6751 6752 6753 6754 6755 6756 6757 6758 6759 6760 6761 6762 6763 ... 7860